Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI
Blood Vessels, Thrombosis & Hemostasis · 2026-05 · 3 (2) · 100160
DOI: 10.1016/j.bvth.2026.100160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-05. Verfasst von Joanne C Clark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingd…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Wellcome Trust, University of Birmingham.
Abstract (Originalsprache)
The platelet immunoreceptor tyrosine-based activation motif receptors, glycoprotein VI (GPVI) and C-type lectin-like receptor 2 (CLEC-2), are activated by a diversity of ligands that bind to distinct epitopes, indicating that competitive antagonists will not block activation by all stimuli. In this study, we used 2-color single-particle tracking to investigate the dynamic nanoscale organization of the 2 receptors in the cell membrane to identify new strategies for inhibition. The studies were performed in CHO-K1 cells that lack the tyrosine kinase Syk. The results show that, when expressed at low level, GPVI and CLEC-2 diffuse over the cell surface as monomers with the presence of dimers due to random collisions. The addition of divalent and trivalent nanobody ligands induces homodimerization and cessation of movement of both receptors proportionate to ligand valency. The dimers of CLEC-2 are longer-lived than those of GPVI, despite a lower affinity of the monomeric nanobody that forms the ligand backbone. The dimerization of recombinant monomeric CLEC-2 but not GPVI was detected by surface plasmon resonance with an affinity constant of 18.5μM. The results suggest that the prolonged lifetime of the CLEC-2 interactions is due to synergy between ligand-induced cross-linking and receptor homodimerization. Blocking dimerization may be an effective way to inhibit the activation of CLEC-2 by its diverse range of ligands.
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.
- Centre of Membrane Proteins and Receptors, The Universities of Birmingham and Nottingham, Birmingham and Nottingham, United Kingdom.
- Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.
Förderung
- British Heart Foundation
- Wellcome Trust
- University of Birmingham
Zitieren
APA
Clark, J. C., Martin, E. M., Slater, A., Calebiro, D., Koszegi, Z., & Watson, S. P. (2026). Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI. Blood Vessels, Thrombosis & Hemostasis, 3(2), 100160. https://doi.org/10.1016/j.bvth.2026.100160
Vancouver
Clark JC, Martin EM, Slater A, Calebiro D, Koszegi Z, Watson SP. Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI. Blood Vessels, Thrombosis & Hemostasis. 2026;3(2):100160. doi:10.1016/j.bvth.2026.100160
BibTeX
@article{Clark2026,
author = {Clark, Joanne C and Martin, Eleyna M and Slater, Alexandre and Calebiro, Davide and Koszegi, Zsombor and Watson, Steve P},
title = {Receptor homodimerization significantly prolongs the lifetime of ligand-induced cross-linking of CLEC-2 but not GPVI},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2026},
volume = {3},
number = {2},
pages = {100160},
doi = {10.1016/j.bvth.2026.100160}
}
EUVIMED